We are live on ! Find out more
FC

Fore Capital Portfolio holdings

AUM $338M Turnover 62.67%
1-Year Est. Return 10.07%
This Fund
S&P 500
This Quarter Est. Return
-0.9%
1 Year Est. Return
+10.07%
3 Year Est. Return
+25.37%
5 Year Est. Return
+23.47%
10 Year Est. Return
–
AUM
$214M
AUM Growth
-$80.2M
Cap. Flow
-$68.7M
Cap. Flow %
-32.1%
Top 10 Hldgs %
68.11%
Holding
64
New
12
Increased
1
Reduced
4
Closed
20
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.4 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.6 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 98.12%
2 Technology 0.84%
3 Financials 0.51%
4 Healthcare 0.37%
5 Communication Services 0.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HYG icon
1
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
$41.1M 19.23%
500,000
+100,000
+25% +$8.36M
2021 Q4
1 quarter
GLD icon
2
CALL
SPDR Gold Trust
GLD
$139B
$32.5M 15.2%
180,000
-420,000
-70% -$73.7M
2021 Q4
1 quarter
SPY icon
3
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$813B
$22.6M 10.56%
+50,000
New +$22.3M
2022 Q1
0 quarters
SLV icon
4
CALL
iShares Silver Trust
SLV
$27B
$14.9M 6.95%
650,000
-1,500,000
-70% -$33.3M
2017 Q4
17 quarters
T icon
5
CALL
AT&T
T
$158B
$5.35M 2.5%
+397,200
New +$7.35M
2022 Q1
0 quarters
NUGT icon
6
CALL
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$899M
$5.1M 2.38%
+72,000
New +$4.09M
2022 Q1
0 quarters
PLL icon
7
CALL
DELISTED
Piedmont Lithium
PLL
$3.29M 1.54%
+45,000
New +$2.53M
2022 Q1
0 quarters
TSLA icon
8
PUT
Tesla
TSLA
$1.45T
$3.23M 1.51%
+9,000
New +$2.8M
2022 Q1
0 quarters
SILC icon
9
Silicom
SILC
$264M
$1.8M 0.84%
45,776
-653
-1% -$27.9K
2021 Q3
2 quarters
WFC.PRL icon
10
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.23B
$1.39M 0.65%
+1,050
New +$1.45M
2022 Q1
0 quarters
TE icon
11
CALL
T1 Energy
TE
$869M
$981K 0.46%
+80,000
New +$766K
2022 Q1
0 quarters
ESNT icon
12
Essent Group
ESNT
$5.65B
$618K 0.29%
+15,000
New +$667K
2022 Q1
0 quarters
MTG icon
13
MGIC Investment
MTG
$5.6B
$474K 0.22%
+35,000
New +$525K
2022 Q1
0 quarters
BMRA icon
14
Biomerica
BMRA
$8.28M
$380K 0.18%
10,625
– –
2021 Q1
4 quarters
CCO icon
15
Clear Channel Outdoor Holdings
CCO
$1.23B
$351K 0.16%
101,524
-30,000
-23% -$102K
2018 Q1
16 quarters
PGEN icon
16
Precigen
PGEN
$2.64B
$285K 0.13%
+135,000
New +$329K
2022 Q1
0 quarters
BAC.PRL icon
17
Bank of America Series L
BAC.PRL
$3.59B
$242K 0.11%
+184
New +$250K
2022 Q1
0 quarters
DFTX icon
18
Definium Therapeutics
DFTX
$4.6B
$111K 0.05%
+6,667
New +$116K
2022 Q1
0 quarters
MTNB icon
19
Matinas BioPharma
MTNB
$2.43M
$8K ﹤0.01%
13
– –
2018 Q1
16 quarters
AZN icon
20
CALL
AstraZeneca
AZN
$251B
– –
-10,000
Closed -$1.17M –
AZN icon
21
AstraZeneca
AZN
$251B
– –
-17,500
Closed -$2.04M –
CHTR icon
22
PUT
Charter Communications
CHTR
$12B
– –
-2,000
Closed -$1.3M –
EPD icon
23
CALL
Enterprise Products Partners
EPD
$77.3B
– –
-390,000
Closed -$8.56M –
EPD icon
24
Enterprise Products Partners
EPD
$77.3B
– –
-20,000
Closed -$439K –
MOS icon
25
CALL
The Mosaic Company
MOS
$6.04B
– –
-50,000
Closed -$1.97M –

Similar funds

Fore Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Fore Capital held 64 positions worth $214M, down 27% from $294M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Fore Capital withdrew a net $68.7M in Q1 2022, closing 20 positions and reducing 4 holdings. Its most notable exit was AstraZeneca, an estimated $2.04M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 98% of assets, up from 96% a quarter earlier, followed by Technology and Financials.

Against the trend, Fore Capital opened a new position in Wells Fargo 7.5% Non Cumv Perp Conv worth $1.39M.

  • Fore Capital's largest Q1 2022 buy was Wells Fargo 7.5% Non Cumv Perp Conv: 1,050 shares worth $1.39M.
  • Fore Capital's biggest Q1 2022 reduction was Clear Channel Outdoor Holdings, cutting an estimated $102K.
  • Fore Capital fully exited AstraZeneca in Q1 2022, selling an estimated $2.04M.
  • Fore Capital's ten largest holdings make up 68% of its $214M portfolio in Q1 2022.
  • Fore Capital opened 12 new positions and closed 20 in Q1 2022.
  • Fore Capital's portfolio value fell 27% quarter-over-quarter to $214M.

Based on Fore Capital's 13F filing for Q1 2022, filed 11 May 2022.